Sign Up to like & get
recommendations!
0
Published in 2019 at "AAPS PharmSciTech"
DOI: 10.1208/s12249-019-1313-3
Abstract: Ziyuglycoside I (ZgI), a major effective ingredient of Sanguisorba officinalis L, has shown good activity in increasing leukocyte of myelosuppression mice. However, oral ZgI therapy has been deterred by poor bioavailability because of its low…
read more here.
Keywords:
activity increasing;
loaded self;
self microemulsifying;
activity ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "International Journal of Nanomedicine"
DOI: 10.2147/ijn.s399568
Abstract: Introduction Radiotherapy and chemotherapy are the fundamental causes of myelosuppression in cancer patients, which usually induce a serious hematopoietic system toxicity, causing the hemocytes and immunity decline of patients. Ziyuglycoside I (ZgI), an active ingredient…
read more here.
Keywords:
gold nanoparticles;
zgi;
zgi aunps;
hematopoietic stem ... See more keywords